Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lies Lahousse

Showing results (1-10 of 211) with videos related to

Pageof 22
Sort By:
The European Respiratory Journal|September 5, 2024
Overweight and dysanapsis in childhood asthmaLies Lahousse
Chest|February 12, 2025
Diabetes and Cardiovascular Mortality Among Restrictive and Preserved Ratio Impaired Spirometry PhenotypesLies Lahousse
Trends in Cardiovascular Medicine|December 20, 2021
Editorial commentary: Which COPD patients benefit from beta-blocker therapy?Lies Lahousse
Breathe (Sheffield, England)|December 7, 2018
Amazing pleiotropic effects of azithromycinLies Lahousse
Chest|November 8, 2021
Personalizing Oral Corticosteroid Dose in Severe COPD ExacerbationsLies Lahousse
Ebiomedicine|April 15, 2019
Epigenetic targets for lung diseasesLies Lahousse
Chest|October 9, 2021
Benefits of Angiotensin-Converting Enzyme Inhibitors and Angiotensin-Receptor Blockers on Progression of Emphysema and Lung Function DeclineXander Bertels, Lies Lahousse
Minerva Medica|May 14, 2021
Monoclonal antibodies in type 2 asthma: an updated network meta-analysisAhmed Edris, Lies Lahousse
Thorax|December 10, 2023
Understanding the aetiology of lung function impairment: the crucial role of age of onsetXander Bertels, Lies Lahousse
Chest|March 11, 2026
May Loss of Smell Serve as an Early Warning Sign of Reduced Pulmonary Function?Valerie Dehondt, Lies Lahousse
Pageof 22

Showing results (1-10 of 211) with videos related to

Sort By:
Pageof 22
The European Respiratory Journal|September 5, 2024
Overweight and dysanapsis in childhood asthmaLies Lahousse
Chest|February 12, 2025
Diabetes and Cardiovascular Mortality Among Restrictive and Preserved Ratio Impaired Spirometry PhenotypesLies Lahousse
Trends in Cardiovascular Medicine|December 20, 2021
Editorial commentary: Which COPD patients benefit from beta-blocker therapy?Lies Lahousse
Breathe (Sheffield, England)|December 7, 2018
Amazing pleiotropic effects of azithromycinLies Lahousse
Chest|November 8, 2021
Personalizing Oral Corticosteroid Dose in Severe COPD ExacerbationsLies Lahousse
Ebiomedicine|April 15, 2019
Epigenetic targets for lung diseasesLies Lahousse
Chest|October 9, 2021
Benefits of Angiotensin-Converting Enzyme Inhibitors and Angiotensin-Receptor Blockers on Progression of Emphysema and Lung Function DeclineXander Bertels, Lies Lahousse
Minerva Medica|May 14, 2021
Monoclonal antibodies in type 2 asthma: an updated network meta-analysisAhmed Edris, Lies Lahousse
Thorax|December 10, 2023
Understanding the aetiology of lung function impairment: the crucial role of age of onsetXander Bertels, Lies Lahousse
Chest|March 11, 2026
May Loss of Smell Serve as an Early Warning Sign of Reduced Pulmonary Function?Valerie Dehondt, Lies Lahousse
Pageof 22